BDRX
Price
$5.65
Change
-$0.06 (-1.05%)
Updated
Sep 5 closing price
Capitalization
3.5M
PRQR
Price
$2.45
Change
+$0.06 (+2.51%)
Updated
Sep 5 closing price
Capitalization
258.09M
60 days until earnings call
Interact to see
Advertisement

BDRX vs PRQR

Header iconBDRX vs PRQR Comparison
Open Charts BDRX vs PRQRBanner chart's image
Biodexa Pharmaceuticals
Price$5.65
Change-$0.06 (-1.05%)
Volume$12.68K
Capitalization3.5M
ProQR Therapeutics
Price$2.45
Change+$0.06 (+2.51%)
Volume$374.45K
Capitalization258.09M
BDRX vs PRQR Comparison Chart in %
Loading...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDRX vs. PRQR commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a Hold and PRQR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BDRX: $5.65 vs. PRQR: $2.45)
Brand notoriety: BDRX and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 17% vs. PRQR: 133%
Market capitalization -- BDRX: $3.5M vs. PRQR: $258.09M
BDRX [@Biotechnology] is valued at $3.5M. PRQR’s [@Biotechnology] market capitalization is $258.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 0 green FA rating(s).

  • BDRX’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 0 green, 5 red.
According to our system of comparison, PRQR is a better buy in the long-term than BDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 5 TA indicator(s) are bullish while PRQR’s TA Score has 6 bullish TA indicator(s).

  • BDRX’s TA Score: 5 bullish, 3 bearish.
  • PRQR’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than PRQR.

Price Growth

BDRX (@Biotechnology) experienced а +1.99% price change this week, while PRQR (@Biotechnology) price change was +8.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PRQR is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($258M) has a higher market cap than BDRX($3.5M). PRQR YTD gains are higher at: -7.547 vs. BDRX (-86.049).
BDRXPRQRBDRX / PRQR
Capitalization3.5M258M1%
EBITDAN/A-35.56M-
Gain YTD-86.049-7.5471,140%
P/E RatioN/AN/A-
RevenueN/A16.5M-
Total CashN/A120M-
Total DebtN/A16.9M-
FUNDAMENTALS RATINGS
BDRX vs PRQR: Fundamental Ratings
BDRX
PRQR
OUTLOOK RATING
1..100
6017
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9642
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDRX's Valuation (15) in the Biotechnology industry is in the same range as PRQR (35). This means that BDRX’s stock grew similarly to PRQR’s over the last 12 months.

BDRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that BDRX’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's SMR Rating (98) in the Biotechnology industry is in the same range as BDRX (99). This means that PRQR’s stock grew similarly to BDRX’s over the last 12 months.

PRQR's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for BDRX (96). This means that PRQR’s stock grew somewhat faster than BDRX’s over the last 12 months.

BDRX's P/E Growth Rating (95) in the Biotechnology industry is in the same range as PRQR (100). This means that BDRX’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDRXPRQR
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACK5.160.21
+4.24%
Ranpak Holdings Corp
BMRN57.771.02
+1.80%
BioMarin Pharmaceutical
NDRA4.270.01
+0.23%
ENDRA Life Sciences Inc
RFIL7.03-0.09
-1.26%
RF Industries Ltd
RSI21.19-0.32
-1.49%
Rush Street Interactive

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with GTBP. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then GTBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-1.08%
GTBP - BDRX
39%
Loosely correlated
+1.72%
KRRO - BDRX
33%
Poorly correlated
+18.14%
SCNI - BDRX
32%
Poorly correlated
-3.85%
ETHZ - BDRX
32%
Poorly correlated
-4.55%
PRQR - BDRX
32%
Poorly correlated
+2.51%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with WVE. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
+2.51%
WVE - PRQR
61%
Loosely correlated
+1.34%
KRRO - PRQR
58%
Loosely correlated
+18.14%
ETHZ - PRQR
44%
Loosely correlated
-4.55%
PHMMF - PRQR
36%
Loosely correlated
N/A
MGTX - PRQR
34%
Loosely correlated
-0.39%
More